Supporting the Global effort to upscale COVID-19 testing
As an ISO 13485 certified and FDA registered facility we have been inundated with requests for assay development and manufacturing support to address the novel SARS-CoV-2 virus.
Over the last ten months we have risen to that challenge and worked with some of the worlds leading authorities in molecular testing to help them develop, modify and mass produce over 4 million tests per week.
Highlights to date include
Biofortuna’s Genomic Services division supporting COVID-19 Testing
As part of the UK government’s call for private UK based labs to support the national testing effort, Biofortuna is currently supporting the Volunteer Testing Network and running critical screening tests at its dual-site facility
Find out how we can help you
To meet this unprecedented demand we have up-scaled our own development and production operation and are now able to offer our experience and resource to more diagnostic test manufacturers than ever before, across a range of sectors.
To find out how we can help you, please click on the Contact us link below.